πŸ‡ΊπŸ‡Έ FDA
Patent

US 8268818

Inhibitors of C-MET and uses thereof

granted A61PA61P1/04A61P1/18

Quick answer

US patent 8268818 (Inhibitors of C-MET and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/04, A61P1/18, A61P11/00, A61P11/06